Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
RHT
vs
S
S&P/ASX 300
RHT
Over the past 12 months, RHT has significantly outperformed S&P/ASX 300, delivering a return of +77% compared to S&P/ASX 300's 3% drop.
Stocks Performance
RHT vs S&P/ASX 300
Performance Gap
RHT vs S&P/ASX 300
Performance By Year
RHT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Resonance Health Ltd
Glance View
Resonance Health Ltd is a medical imaging company that turns MRI and other scan data into measurements doctors and drug companies can use. Its core work is image analysis, especially reading scans for liver iron, liver fat, and related conditions where precise measurement matters. The company also develops imaging software and related tools that help standardize how scans are processed. Its main customers are hospitals, specialist doctors, clinical research groups, and pharmaceutical companies running clinical trials. These customers pay for Resonance Health’s analysis services or license its software because they need reliable, repeatable results from medical images. The company makes money by charging for scan analysis projects, software use, and services tied to trial support and research workflows. What makes the business different is that it sits between healthcare and data analysis. It does not make drugs or sell imaging machines; instead, it helps other companies and clinicians extract useful measurements from scans. That gives Resonance Health a specialized role in diseases where tracking changes inside the body is hard to do with simple lab tests alone.
